PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30590314-0	2019	Erianin induces cell apoptosis through ERK pathway in human nasopharyngeal carcinoma.	Erianin	0-7	mitogen-activated protein kinase 1	Homo sapiens	39-42	
32677672-0	2020	Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways.	Erianin	0-7	mitogen-activated protein kinase 1	Homo sapiens	95-98	
32677672-0	2020	Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways.	Erianin	0-7	mitogen-activated protein kinase 1	Homo sapiens	99-103	
32677672-13	2020	For the molecular mechanism, erianin inhibited the phosphorylation of Akt, ERK and P38 in the PI3K/Akt and ERK/P38 pathway.	Erianin	29-36	mitogen-activated protein kinase 1	Homo sapiens	75-78	
32677672-13	2020	For the molecular mechanism, erianin inhibited the phosphorylation of Akt, ERK and P38 in the PI3K/Akt and ERK/P38 pathway.	Erianin	29-36	mitogen-activated protein kinase 1	Homo sapiens	107-110	
32677672-14	2020	CONCLUSION: We demonstrated, for the first time, that erianin inhibited the proliferation, migration, invasion and induced the apoptosis of HCC through PI3K/Akt, p38 and ERK MAPK signaling pathway, indicating that erianin is a promising agent for the HCC treatment.	Erianin	54-61	mitogen-activated protein kinase 1	Homo sapiens	170-173	
32677672-14	2020	CONCLUSION: We demonstrated, for the first time, that erianin inhibited the proliferation, migration, invasion and induced the apoptosis of HCC through PI3K/Akt, p38 and ERK MAPK signaling pathway, indicating that erianin is a promising agent for the HCC treatment.	Erianin	54-61	mitogen-activated protein kinase 1	Homo sapiens	174-178